These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 7383641)
1. [The value of the so-called drug chart]. Füzéki B; Szarvas F Orv Hetil; 1980 Mar; 121(11):671-2. PubMed ID: 7383641 [No Abstract] [Full Text] [Related]
5. Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances. Joranson DE NIDA Res Monogr; 1993; 131():18-34. PubMed ID: 8413529 [No Abstract] [Full Text] [Related]
6. The new drug marketing: a consumer protection perspective. Woodward D Food Drug Law J; 1996; 51(4):637-50. PubMed ID: 11797733 [No Abstract] [Full Text] [Related]
7. Pharmaceutical companies may not practice what they preach. Ponedal SA Am J Hosp Pharm; 1987 Oct; 44(10):2253-4. PubMed ID: 3687958 [No Abstract] [Full Text] [Related]
8. [What is wrong with drugs?]. Káldor A Orv Hetil; 1980 Apr; 121(14):811-2. PubMed ID: 7383657 [No Abstract] [Full Text] [Related]
9. Independent nurse prescribing in New Zealand. Moller P; Begg E N Z Med J; 2005 Nov; 118(1225):U1724. PubMed ID: 16286938 [No Abstract] [Full Text] [Related]
10. Pain, patients, and prosecution: who is deceiving whom? Ziegler SJ Pain Med; 2007; 8(5):445-6; author reply 447-8. PubMed ID: 17661861 [No Abstract] [Full Text] [Related]
11. Nurse practitioner (NP) prescribing in New Zealand: a NP's response to the editorial by Drs Moller and Begg. Renouf P N Z Med J; 2005 Nov; 118(1226):U1764; author reply U1764. PubMed ID: 16311618 [No Abstract] [Full Text] [Related]
12. [Carrying out medical prescriptions. Difficulties of a daily practice]. Miègeville M Soins; 1998 Mar; (623):43-6. PubMed ID: 9601457 [No Abstract] [Full Text] [Related]
13. [Changes in the condition for the use of Cavinton and Devincan. New regulation concerning the prescription and use of these 2 drugs]. Orv Hetil; 1980 Jun; 121(25):1525-6. PubMed ID: 7454263 [No Abstract] [Full Text] [Related]
14. DEA and Schedule II "do not fill prescriptions"--disappointing enforcement activity. Bolen J Pain Med; 2006; 7(1):80-5. PubMed ID: 16533205 [No Abstract] [Full Text] [Related]
15. [Guiding principles for the interpretation of reimbursement categories applicable in definite indications of psychiatric drugs]. Bánki CM Psychiatr Hung; 2007; 22(1):82-8. PubMed ID: 17642122 [No Abstract] [Full Text] [Related]
16. [Charter of medicines promotion and rational use by physicians]. Baumevieille M; Bégaud B; Maurain C Therapie; 2007; 62(1):39-44. PubMed ID: 17374346 [TBL] [Abstract][Full Text] [Related]
17. Pain, the DEA, and the impact on patients. Rowe W Pain Med; 2006; 7(1):86. PubMed ID: 16533206 [No Abstract] [Full Text] [Related]
18. [Recommendation of the Health Sciences Council's Presidency regarding the legal prerequisites for the legal use of AVEMAR dietary supplement as a neoplastic agent]. Egészségügyi Tudományos Tanács Elnöksége Orv Hetil; 2007 Jan; 148(4):173. PubMed ID: 17344132 [No Abstract] [Full Text] [Related]